Analyzing the Relationship Between Biomarkers, Testing Rates, and Clinical Characteristics in Non-Small Cell Lung Cancer

Jason Porter, MD, and fellow panelists discuss how expression of NSCLC biomarkers and biomarker testing rates may vary by patients’ clinical characteristics, including tumor histology, stage, race, and sex.

Related Videos
Expert on NSCLC
Experts on NSCLC
Experts on renal cell carcinoma
Expert on NSCLC
Expert on NSCLC
Expert on lung cancer